Magnus Medical announced the commercial launch of its Saint neuromodulation system for treatment-resistant major depressive disorder (MDD). The Saint treatment changes a patient’s brain...
NICO Corporation is set to launch the new Myriad SPECTRA System, a device for fluorescence-guided surgical removal of high-grade glioma brain tumours.
The new handheld...
SimBioSys has entered a strategic collaboration with augmented reality (AR) firm Magic Leap to integrate AI and AR for improved cancer surgery outcomes.
This partnership...
Exo announced that it launched its FDA-cleared cardiac and lung AI applications for the Iris handheld ultrasound device.The company now has FDA clearance for...
Neuronoff announced it completed the first-in-human clinical trial evaluating its flagship Injectrode neuromodulation product. The Cleveland-based company designed Injectrode to treat chronic pain. The...
Hyalex Orthopaedics announced today that patients successfully received knee implants as part of its first-in-human clinical trials.
The procedures came as part of two prospective,...
